NOTCH1 gene amplification promotes expansion of Cancer Associated Fibroblast populations in human skin

• Published in: Nature communications 2020-10, Vol.11 (1), p.1-14, Article 5126
• Main Authors: Katarkar, Atul, Bottoni, Giulia, Clocchiatti, Andrea, Goruppi, Sandro, Bordignon, Pino, Lazzaroni, Francesca, Gregnanin, Ilaria, Ostano, Paola, Neel, Victor, Dotto, G. Paolo
• Format: Article
• Language: English
• Subjects: 13/106; 38/22; 38/32; 631/67/1813/1352; 631/67/327; 96/2; Humanities and Social Sciences; multidisciplinary; Science; Science (multidisciplinary)
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-020-18919-2

Cancer associated fibroblasts (CAFs) are a key component of the tumor microenvironment. Genomic alterations in these cells remain a point of contention. We report that CAFs from skin squamous cell carcinomas (SCCs) display chromosomal alterations, with heterogeneous NOTCH1 gene amplification and overexpression that also occur, to a lesser extent, in dermal fibroblasts of apparently unaffected skin. The fraction of the latter cells harboring NOTCH1 amplification is expanded by chronic UVA exposure, to which CAFs are resistant. The advantage conferred by NOTCH1 amplification and overexpression can be explained by NOTCH1 ability to block the DNA damage response (DDR) and ensuing growth arrest through suppression of ATM-FOXO3a association and downstream signaling cascade. In an orthotopic model of skin SCC, genetic or pharmacological inhibition of NOTCH1 activity suppresses cancer/stromal cells expansion. Here we show that NOTCH1 gene amplification and increased expression in CAFs are an attractive target for stroma-focused anti-cancer intervention. The presence of genomic alterations in cancer associated fibroblasts (CAFs) is largely unexplored. The authors show that frequent NOTCH1 gene amplification and overexpression render CAFs resistant to the UVA-induced DNA damage response (DDR) and promote cancer/stromal cells expansion, which can be reversed by NOTCH inhibition.